Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,314 | -5,604 | -22,242 | -17,138 | -13,617 |
| Depreciation Amortization | 359 | 185 | 862 | 641 | 441 |
| Income taxes - deferred | N/A | N/A | 220 | N/A | N/A |
| Other Working Capital | 741 | 103 | -32 | 613 | 1,970 |
| Other Operating Activity | -2,264 | -2,328 | -3,283 | -3,670 | 382 |
| Operating Cash Flow | $-13,478 | $-7,645 | $-24,476 | $-19,554 | $-10,825 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -10 | -10 | -10 |
| Net Acquisitions | N/A | N/A | 2,445 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -5 | -5 | -2 |
| Other Investing Activity | 504 | 253 | 502 | 281 | 109 |
| Investing Cash Flow | $504 | $253 | $2,938 | $271 | $99 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -30,093 | -29,976 | -30,637 |
| Other Financing Activity | -302 | -151 | -4,864 | -4,692 | -338 |
| Financing Cash Flow | $-302 | $-151 | $-34,957 | $-34,668 | $-30,976 |
| Exchange Rate Effect | 13 | 2 | 1,616 | 2,051 | 444 |
| Beginning Cash Position | 27,628 | 27,457 | 83,451 | 83,125 | 84,959 |
| End Cash Position | 14,364 | 19,916 | 28,571 | 31,224 | 43,701 |
| Net Cash Flow | $-13,263 | $-7,541 | $-54,879 | $-51,901 | $-41,258 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,478 | -7,645 | -24,476 | -19,554 | -10,825 |
| Capital Expenditure | N/A | N/A | -10 | -10 | -10 |
| Free Cash Flow | -13,478 | -7,645 | -24,486 | -19,564 | -10,835 |